author-photo

Danny Shih

Genentech

6

Papers

671

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

ATHENA (GOG-3020/ENGOT-ov45): a randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA-MONO) and rucaparib in combination with nivolumab (ATHENA-COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian cancer.

2021 International Journal of Gynecological Cancer
Show All
- Source
- Cite
- Save
Citations (1)
Efficacy and Safety of Rociletinib Versus Chemotherapy in Patients With EGFR-Mutated Non–Small Cell Lung Cancer: Results of TIGER-3, a Phase III Randomized Study

2020
Show All
- Source
- Cite
- Save
Citations (2)
Abstract CT158: ATHENA (GOG-3020/ENGOT-ov45): a randomized, double-blind, placebo-controlled, Phase III study of rucaparib + nivolumab following front-line platinum-based chemotherapy in ovarian cancer

2019 Clinical Trials
Show All
- Source
- Cite
- Save
Citations (7)
Species-dependent serum interference in a sandwich ELISA for Apo2L/TRAIL.

2007 Journal of Immunological Methods
Show All
- Source
- Cite
- Save
Citations (7)
Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions

2001 Nature Medicine
Show All
- Source
- Cite
- Save
Citations (649)